Clinical trials: Smoking Cessation, completed
Smoking, Tobacco
Impact of Positive Mental Vs. Physical Health Messaging on Motivation to Stop Smoking
This study tested whether positive messages on tobacco packaging about the mental health benefits of quitting smoking could help motivate people to stop smoking.
- Trial name
- NCT06762756
- Testing
- Messages on tobacco packaging labels
- Where
- United Kingdom
- Volunteers
- 631 people, healthy volunteers welcome
- Sponsor
- Katherine Sawyer
Smoking Cessation
Inspired: Smartphone Videogame-Based Smoking Cessation Intervention
The investigators are testing a new, smartphone videogame-based intervention for smoking cessation.
- Trial name
- NCT03929003
- Testing
- Inspired
- Where
- United States
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Rowan University
Nicotine Dependence, E-Cig Use
Research and Innovation to Stop E-cigarette/Vaping in Young Adults
The aim of this study is to test intervention components to help young adults quit vaping. A 2x2 factorial design will be used where all participants receive quitline-delivered behavioral phone counseling, and components to be…
- Trial name
- (RISE) (NCT04974580)
- Testing
- Nicotine patch, Phone Counseling, Digital Coaching
- Where
- United States
- Volunteers
- 508 people, healthy volunteers welcome
- Sponsor
- Ohio State University
Glucagon-like Peptide-1, Smoking Cessation
Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
Cigarette smoking is the leading preventable cause of premature death worldwide. However smoking is a very difficult addiction to break whereby main reasons for not quitting or relapsing after cessation are the nicotine…
- Conditions
- Glucagon-like Peptide-1, Smoking Cessation, Weight Change, Body, Craving
- Trial name
- SKIP (NCT03204396)
- Testing
- Dulaglutide, 0.5 ml normal saline (0.9% sodium chloride [0.9% NaCl])
- Where
- Switzerland
- Volunteers
- 256 people, healthy volunteers welcome
- Sponsor
- University Hospital, Basel, Switzerland
Smoking, Smoking Cessation
Wisconsin Tobacco Quit Line Medicaid Incentive Evaluation
The study is designed to test the hypotheses that financial incentives can increase both participation in smoking cessation treatment and resulting cessation rates, when they are offered to BadgerCare Plus (Medicaid) smokers as…
- Conditions
- Smoking, Smoking Cessation, Nicotine Dependence
- Trial name
- NCT02713594
- Testing
- Counseling from WTQL, Financial incentive to participate
- Volunteers
- 1,900 people, healthy volunteers welcome
- Sponsor
- University of Wisconsin, Madison
Tobacco Smoking
Development of a Tailored Smoking Cessation Program for Individuals With HIV Infection in Washington, D.C.
Morbidity and mortality from smoking-related diseases among people living with HIV (PLWH) in the U.S. surpasses that due to HIV itself. Conventional smoking cessation treatments have not demonstrated strong efficacy among PLWH.
- Trial name
- NCT04594109
- Testing
- Tailored behavioral counseling, Standard of Care
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Colorado State University
Nicotine Addiction
Investigation of Cycloserine as a Smoking Cessation Treatment
Psychosocial treatments for drug abuse benefit some patients (Rawson et al 2004), but there is an urgent need for new treatment approaches that can improve treatment outcomes.
- Trial name
- NCT01062932
- Testing
- Cycloserine
- Where
- United States
- Volunteers
- 34 people
- Sponsor
- Baylor College of Medicine
Physical Activity, Fruits and Vegetable Consumption
A Web-enabled Integrated Care Pathway (ICP) for Addressing Multiple Modifiable Risk Factors as a Part of Smoking Cessation Treatment in Primary Care Settings.
Compared to non-smokers, smokers are significantly more likely to also engage in other chronic disease-related risk behaviours; which can be a barrier to quitting successfully.
- Conditions
- Physical Activity, Fruits and Vegetable Consumption, Smoking Cessation
- Trial name
- NCT04223336
- Testing
- Brief physical activity and diet intervention
- Where
- Canada
- Volunteers
- 5,331 people
- Sponsor
- Centre for Addiction and Mental Health
Nicotine Dependence
Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation
The lack of proven waterpipe smoking cessation interventions makes it important to explore interventions proven effective for cigarette smoking cessation.
- Trial name
- NCT02575183
- Testing
- Varinecline (Chantix), Behavioral Therapy
- Where
- 2 sites in Lebanon
- Volunteers
- 152 people
- Sponsor
- American University of Beirut Medical Center
Nicotine Dependence
Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation
Smoking while on nicotine patches will help subjects to reduce their expired carbon monoxide levels from the levels they were before they started using the patch. Subjects will also decrease their daily consumption of cigarettes.
- Trial name
- NCT00289653
- Testing
- Nicoderm
- Where
- Canada
- Volunteers
- 23 people
- Sponsor
- Centre for Addiction and Mental Health
Smoking
Testing Methods of Self-persuasion Involving Cigarette Smoking
Smokers who are not actively engaged in quitting will participate in a study using self-generated text and audio text messages containing reasons to quit smoking.
- Trial name
- NCT02069483
- Testing
- Motivational Interviewing, Tailored Feedback
- Where
- United States
- Volunteers
- 48 people
- Sponsor
- Duke University
Smoking Cessation
Zonisamide/Bupropion Effects on Switching to Electronic Cigarettes
This single-group, small-scale, open-label study (N= 25 to 50) will evaluate the impact of combination zonisamide and bupropion on the process of switching from combustible cigarettes (CC) to an e-cigarette.
- Trial name
- BuZonE (NCT04388319)
- Testing
- Zonisamide, Bupropion, Halo G6 e-cigarette
- Where
- 2 sites in United States
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- Rose Research Center, LLC
Smoking Cessation
A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation
The purpose of the study is to measure the safety and efficacy of three doses of varenicline for smoking cessation.
- Trial name
- NCT00150241
- Testing
- CP-526,555 (varenicline)
- Where
- 7 sites in United States
- Volunteers
- 625 people
- Sponsor
- Pfizer
Smoking Cessation
Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants
This is a 24 month pilot project that will implement and evaluate an innovative program that integrates financial counseling with smoking cessation counseling for low-income immigrants.
- Trial name
- NCT03187730
- Testing
- Integrated Smoking Cessation and Financial Counseling, Waitlist Integrated Smoking Cessation and Financial Counseling, Nicotine Replacement Therapy (NRT)
- Where
- United States
- Volunteers
- 410 people
- Sponsor
- NYU Langone Health
Smoking
Evaluating a Telemedicine Smoking Cessation Program in Rural Primary Care Practices
People who smoke cigarettes and live in rural areas may not have access to a wide variety of resources to help them stop smoking.
- Trial name
- NCT00843505
- Testing
- Telemedicine Smoking Cessation Program, Telephone Quitline Smoking Cessation Program
- Where
- United States
- Volunteers
- 566 people
- Sponsor
- Kimber Richter, PhD, MPH, MA
Smoking Cessation
PMCAN for Smokers at Smoking Hotspots
Background: Many smokers cannot quit due to nicotine withdrawal symptoms, which peak at the first week of abstinence. Proactive recruitment of smokers is needed as most smokers do not seek smoking cessation (SC) services.
- Trial name
- NCT02935231
- Testing
- Nicotine Replacement Therapy (NRT), Minimal Cessation Advice (MCA), Health warning leaflet
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- The University of Hong Kong
Smoking Cessation
12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation.
The purpose of the study is to measure the safety and efficacy of four dosing strategies of CP-526,555 for 12 weeks compared with placebo for smoking cessation.
- Trial name
- NCT00150254
- Testing
- CP-526,555 (varenicline)
- Where
- 13 sites in United States
- Volunteers
- 625 people
- Sponsor
- Pfizer
Tobacco Smoking
Promoting Evidenced-Based Tobacco Smoking Cessation Treatment in Community Mental Health Clinics
This pilot study will examine whether an implementation intervention will improve delivery of evidence-based treatment for tobacco smoking cessation for patients in community mental health clinics.
- Trial name
- IMPACT (NCT04796961)
- Testing
- Implementation Intervention
- Where
- United States
- Volunteers
- 91 people, healthy volunteers welcome
- Sponsor
- Johns Hopkins University
Smoking Cessation, Tobacco Use
Mobile-based Peer Mentoring for Smoking Cessation
Despite the availability of a variety of effective treatments for smoking cessation, uptake of treatments is low. The increasing use of smartphone technology presents an exceptional opportunity to expand access to low-cost…
- Trial name
- NCT03048786
- Testing
- Control, Peer Mentoring
- Where
- United States
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- University of California, San Francisco
Smoking, Veterans
Mobile Contingency Management for Smoking Cessation in Returning US Veterans
The primary goal of the study is to evaluate the effectiveness of a combined tele-health and contingency management (CM) intervention that the investigators call mobile CM, or mCM, in promoting smoking abstinence in US Veterans.
- Trial name
- NCT02513069
- Testing
- Nicotine gum, mobile contingency management, Telephone counseling
- Where
- United States
- Volunteers
- 291 people
- Sponsor
- Duke University
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.